Avandia and Personal Injury

Ed Van Dorn
Ed Van Dorn
Contributor
Posted by Ed Van DornJuly 30, 2007 8:18 PM

Yet another drug maker has come under attack for not disclosing that one of its drugs may cause serious heart problems. This time its the drug Avandia and the maker is GlaxoSmithKline.

Today's New York Times reports about this dangerous drug

A federal drug safety official recommended during an advisory committee hearing today that Avandia, a controversial diabetes medicine made by GlaxoSmithKline, be withdrawn from the market because it increases heart risks.

If you or a loved one has suffered heart damage through the use of the drug Avandia you may have a defective product claim against the drug's maker GlaxoSmithKline. Under Vermont product liability law a manufacturer of an unreasonalby dangerous drug may have a product liability claim against its maker. Pharmaceutical claims can be complicated so if you are thinking of legal action you should consult an attorney with experience in product liability law. I have been handling product liability cases for 30 years. My firm offers free consultations.

For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Vermont

InjuryBoard Vermont RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address